Resistance to chemotherapy remains a major barrier to the successful treatment of cancer. To understand mechanisms underlying docetaxel resistance in breast cancer, we use an insertional mutagenesis strategy to identify proteins whose overexpression confers resistance, scientists writing in the journal

Conventional treatments have never offered much help to patients with brain cancer. So doctors at the University of California-San Francisco are trying an entirely new approach, enlisting the patient's own immune system to attack the tumor.

A new class of agents found in soy may prevent or even treat cancer, U.S. scientists suggest. Study leader Dr. Julie Saba of California's Children's Hospital Oakland Research Institute said the agents -- natural lipid molecules called sphingadienes -- may

Enzo Biochem, Inc. announced that it has entered into an agreement with GeneNews, of Toronto, Canada, for exclusive rights to market GeneNews' ColonSentry, a proprietary blood test for colorectal cancer, in the states of New York and New Jersey.

Researchers at the University of Wisconsin- Madison School of Medicine and Public Health have identified a molecular mechanism that allows two powerful signaling pathways to interact and begin a process leading to colorectal tumors.

Researchers at the University of Wisconsin- Madison School of Medicine and Public Health have identified a molecular mechanism that allows two powerful signaling pathways to interact and begin a process leading to colorectal tumors.

Poniard Pharmaceuticals, Inc. announced updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC).

Study results published in Clinical Cancer Research showed that ZOLINZA (vorinostat) was not associated with QTc prolongation - a change in electrical activity of the heart - in patients with advanced cancer (including solid tumors, hematologic malignancies and lymphoma).

The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Clinical Practice Guidelines in Oncology" for Breast Cancer Screening and Diagnosis and continues to recommend annual clinical breast examinations and mammography for women 40 years and older at normal risk.

A radiation breakthrough to treat breast cancer patients in one day, as opposed to the current average of six weeks, has arrived at Cancer Treatment Centers of America (CTCA) in Philadelphia. CTCA will become the first in the country to

In addition to building muscle, weightlifting is also a prescription for self-esteem among breast cancer survivors, according to new University of Pennsylvania School of Medicine research. Breast cancer survivors who lift weights regularly feel better about bodies and their appearance

HistoRx announced that the Company's proprietary AQUA technology, an automated image analysis platform based on tissue-based quantitative immunofluorescence, was noted in a recent National Comprehensive Cancer Network (NCCN) Task Force Report on hormone receptor testing in breast cancer as one

An implanted vaccine eliminated melanoma tumors in mice, offering hope of improved treatment for people with skin cancer, U.S. researchers said.

According to recent research from the United States, The increasing incidence of hepatocellular carcinoma in the United States is only partially accounted for by hepatitis C virus (HCV) infections. The prevalence of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis (NASH)

Today, Lung Cancer Alliance (LCA) released its annual National Report Card on Lung Cancer, an overall assessment of efforts to reduce lung cancer's mortality.

A combination of imaging tests conducted six to eight weeks after patients complete chemoradiotherapy for head and neck cancer may help identify patients who will respond to treatment and those who will require surgical follow-up, according to a report in

According to a study from the United States, Paclitaxel is used in the treatment of most gynecologic malignancies. It is solubilized in Cremophor EL, a polyoxyethylated castor oil agent responsible for the high rate of paclitaxel-associated hypersensitivity reactions.

Just because the American College of Obstetricians and Gynecologists has lengthened the period of time most women can wait between cervical cancer screenings doesn't mean they should feel free to see their gynecologist less frequently, too, local doctors warned.

Off-road racer Joe Bacal took control of cancer when he learned he had Hodgkin's lymphoma at age 38. He represents strength and recently finished the Baja 1000 in 2nd place, after driving for 27 hours straight. Joe couldn't have accomplished

An independent study by the Institute of Medicine last month resulted in broadened health coverage by the Veterans Affairs Department for Vietnam War veterans who were exposed to Agent Orange.